Kyla H Thomas Selected Research

Varenicline (Chantix)

10/2021	Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
1/2021	Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.
1/2021	Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
1/2020	Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
1/2020	Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.
12/2019	Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study.
1/2018	The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records.
1/2017	How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.
5/2016	Nicotine receptor partial agonists for smoking cessation.
11/2015	What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyla H Thomas Research Topics

Disease

4	Myocardial Infarction 01/2021 - 11/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2018
1	Mental Disorders (Mental Disorder) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Neurotic Disorders (Neuroses) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Neurodevelopmental Disorders 12/2019
1	Pain (Aches) 11/2017
1	Chronic Pain 11/2017
1	Cancer Pain 11/2017
1	Nausea 05/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Sleep Wake Disorders 03/2015
1	Fatigue 03/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Acne Vulgaris 09/2014
1	Poisoning 01/2013

Drug/Important Bio-Agent (IBA)

12	Varenicline (Chantix)FDA Link 10/2021 - 09/2014
4	Bupropion (Wellbutrin)FDA LinkGeneric 10/2021 - 09/2014
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Opioid Analgesics (Opioids)IBA 11/2017
1	Nicotine FDA Link 05/2016
1	Dopamine (Intropin)FDA LinkGeneric 05/2016
1	RimonabantIBA 09/2014
1	Isotretinoin (Accutane)FDA LinkGeneric 09/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2014
1	Paroxetine (Paxil)FDA LinkGeneric 09/2014
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 09/2014
1	Disinfectants (Biocides)IBA 01/2013

Therapy/Procedure

7	Nicotine Replacement Therapy 10/2021 - 11/2015